Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in

Mario Monaco1, Paolo Stassano, Luigi Di Tommaso

  • 1Unit of Cardiovascular Surgery, Istituto Clinico Pineta Grande, Castelvolturno, Italy.

Insights

Routine coronary angiography improved long-term survival for high-risk peripheral arterial disease surgery patients. This strategy positively impacted outcomes, demonstrating its value in cardiovascular risk management.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Vascular surgery patients face high cardiovascular risks (15-20% complications, 3-5% mortality) despite risk stratification.
  • Current guidelines do not fully mitigate these perioperative risks.
  • Identifying optimal pre-operative strategies remains crucial.

Purpose of the Study:

  • To evaluate the impact of systematic coronary angiography versus selective angiography on patient outcomes.
  • To assess both immediate and long-term effects in medium-high risk surgical patients.
  • To determine if routine pre-operative angiography improves survival and reduces adverse events.

Main Methods:

  • A randomized trial involving 208 patients undergoing major vascular surgery with a revised cardiac risk index >=2.
  • Group A (n=103) received selective coronary angiography based on noninvasive tests.
  • Group B (n=105) underwent systematic pre-operative coronary angiography.

Main Results:

  • Systematic angiography led to higher myocardial revascularization rates (58.1% vs 40.1%, p=0.01).
  • In-hospital major adverse cardiovascular events were not significantly reduced (p=0.07).
  • Long-term follow-up (58 months) showed significantly better survival (p=0.01) and freedom from death/cardiovascular events (p=0.003) in the systematic group.

Conclusions:

  • Routine coronary angiography significantly improves long-term outcomes for high-risk peripheral arterial disease surgical patients.
  • This is the first randomized trial to demonstrate this benefit.
  • Further multicenter trials are recommended to validate these findings in a larger cohort.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...